{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T19:05:09Z","timestamp":1783191909275,"version":"3.54.6"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,9]]},"DOI":"10.7759\/cureus.89686","type":"journal-article","created":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T13:55:46Z","timestamp":1754747746000},"source":"Crossref","is-referenced-by-count":1,"title":["Severe Metformin-Associated Lactic Acidosis Managed Without Dialysis in an Elderly Patient With Multiple Comorbidities: A Case Report"],"prefix":"10.7759","author":[{"given":"Hironobu","family":"Sasaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuma","family":"Yagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Uratsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Koide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI40671","article-title":"Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1\/AMPK pathway via a decrease in hepatic energy state","volume":"120","author":"Foretz M","year":"2010","unstructured":"Foretz M, H\u00e9brard S, Leclerc J, et al.. Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1\/AMPK pathway via a decrease in hepatic energy state. J Clin Invest. 2010, 120:2355-69. 10.1172\/JCI40671","journal-title":"J Clin Invest"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2007.00801.x","article-title":"Effects of metformin on peripheral insulin sensitivity and intracellular lipid contents in muscle and liver of overweight Japanese subjects","volume":"10","author":"Tamura Y","year":"2008","unstructured":"Tamura Y, Watada H, Sato F, et al.. Effects of metformin on peripheral insulin sensitivity and intracellular lipid contents in muscle and liver of overweight Japanese subjects. Diabetes Obes Metab. 2008, 10:733-8. 10.1111\/j.1463-1326.2007.00801.x","journal-title":"Diabetes Obes Metab"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","unstructured":"UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998, 352:854-865. 10.1016\/s0140-6736(98)07037-8","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2337\/dci22-0034","article-title":"Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"45","author":"Davies MJ","year":"2022","unstructured":"Davies MJ, Aroda VR, Collins BS, et al.. Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2022, 45:2753-86. 10.2337\/dci22-0034","journal-title":"Diabetes Care"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.13922","article-title":"Changes in prescription patterns and doses of oral antidiabetic drugs in Japanese patients with type\u20092 diabetes (JDDM70)","volume":"14","author":"Shirabe S","year":"2023","unstructured":"Shirabe S, Yamazaki K, Oishi M, et al.. Changes in prescription patterns and doses of oral antidiabetic drugs in Japanese patients with type\u20092 diabetes (JDDM70). J Diabetes Investig. 2023, 14:75-80. 10.1111\/jdi.13922","journal-title":"J Diabetes Investig"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-017-0640-4","article-title":"Serum lactate level and mortality in metformin-associated lactic acidosis requiring renal replacement therapy: a systematic review of case reports and case series","volume":"18","author":"Yeh HC","year":"2017","unstructured":"Yeh HC, Ting IW, Tsai CW, Wu JY, Kuo CC. Serum lactate level and mortality in metformin-associated lactic acidosis requiring renal replacement therapy: a systematic review of case reports and case series. BMC Nephrol. 2017, 18:229. 10.1186\/s12882-017-0640-4","journal-title":"BMC Nephrol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-023-04201-8","article-title":"Treatment of severe metformin-associated lactic acidosis with renal replacement therapy and tris-hydroxymethyl aminomethane: a case report","volume":"17","author":"Yusim D","year":"2023","unstructured":"Yusim D, Tiru B, Abdullin M, Landry DL, Hodgins S, Braden GL. Treatment of severe metformin-associated lactic acidosis with renal replacement therapy and tris-hydroxymethyl aminomethane: a case report. J Med Case Rep. 2023, 17:462. 10.1186\/s13256-023-04201-8","journal-title":"J Med Case Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3689","article-title":"Mortality rate in so-called \"metformin-associated lactic acidosis\": a review of the data since the 1960s","volume":"23","author":"Kajbaf F","year":"2014","unstructured":"Kajbaf F, Lalau JD. Mortality rate in so-called \"metformin-associated lactic acidosis\": a review of the data since the 1960s. Pharmacoepidemiol Drug Saf. 2014, 23:1123-7. 10.1002\/pds.3689","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-3023","article-title":"Risk of lactic acidosis or elevated lactate concentrations in metformin users with renal impairment: a population-based cohort study","volume":"37","author":"Eppenga WL","year":"2014","unstructured":"Eppenga WL, Lalmohamed A, Geerts AF, et al.. Risk of lactic acidosis or elevated lactate concentrations in metformin users with renal impairment: a population-based cohort study. Diabetes Care. 2014, 37:2218-24. 10.2337\/dc13-3023","journal-title":"Diabetes Care"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000001002","article-title":"Extracorporeal treatment for metformin poisoning: systematic review and recommendations from the extracorporeal treatments in poisoning workgroup","volume":"43","author":"Calello DP","year":"2015","unstructured":"Calello DP, Liu KD, Wiegand TJ, et al.. Extracorporeal treatment for metformin poisoning: systematic review and recommendations from the extracorporeal treatments in poisoning workgroup. Crit Care Med. 2015, 43:1716-30. 10.1097\/CCM.0000000000001002","journal-title":"Crit Care Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2015.10.014","article-title":"Metformin-associated lactic acidosis: current perspectives on causes and risk","volume":"65","author":"DeFronzo R","year":"2016","unstructured":"DeFronzo R, Fleming GA, Chen K, Bicsak TA. Metformin-associated lactic acidosis: current perspectives on causes and risk. Metabolism. 2016, 65:20-9. 10.1016\/j.metabol.2015.10.014","journal-title":"Metabolism"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0273678","article-title":"Metformin-associated lactic acidosis and factors associated with 30-day mortality","volume":"17","author":"Thammavaranucupt K","year":"2022","unstructured":"Thammavaranucupt K, Phonyangnok B, Parapiboon W, et al.. Metformin-associated lactic acidosis and factors associated with 30-day mortality. PLoS One. 2022, 17:e0273678. 10.1371\/journal.pone.0273678","journal-title":"PLoS One"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-018-0875-8","article-title":"Metformin associated lactic acidosis: a case series of 28 patients treated with sustained low-efficiency dialysis (SLED) and long-term follow-up","volume":"19","author":"Angioi A","year":"2018","unstructured":"Angioi A, Cabiddu G, Conti M, et al.. Metformin associated lactic acidosis: a case series of 28 patients treated with sustained low-efficiency dialysis (SLED) and long-term follow-up. BMC Nephrol. 2018, 19:77. 10.1186\/s12882-018-0875-8","journal-title":"BMC Nephrol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.5262\/tndt.2015.1001.21","article-title":"Metformin-associated lactic acidosis: a case report","volume":"24","author":"\u0130nal S","year":"2015","unstructured":"\u0130nal S, Ulusal Okyay G, Arma\u011fan B, Arinsoy T. Metformin-associated lactic acidosis: a case report. Turk Neph Dial Transpl. 2015, 24:126-8. 10.5262\/tndt.2015.1001.21","journal-title":"Turk Neph Dial Transpl"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.48683","article-title":"Metformin-associated lactic acidosis in individuals without chronic kidney disease on therapeutic dose: a case report","volume":"15","author":"Fukuda M","year":"2023","unstructured":"Fukuda M, Hirayu N, Nabeta M, Goto M, Takasu O. Metformin-associated lactic acidosis in individuals without chronic kidney disease on therapeutic dose: a case report. Cureus. 2023, 15:e48683. 10.7759\/cureus.48683","journal-title":"Cureus"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2147\/IJNRD.S266864","article-title":"The impact of intravenous fluid therapy on acid-base status of critically ill adults: a Stewart approach-based perspective","volume":"13","author":"Kilic O","year":"2020","unstructured":"Kilic O, Gultekin Y, Yazici S. The impact of intravenous fluid therapy on acid-base status of critically ill adults: a Stewart approach-based perspective. Int J Nephrol Renovasc Dis. 2020, 13:219-30. 10.2147\/IJNRD.S266864","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"ref17","article-title":"The therapeutic role of vasopressin on improving lactate clearance during and after vasogenic shock: microcirculation, is it the black box?","volume":"54","author":"Barzegar E","year":"2016","unstructured":"Barzegar E, Ahmadi A, Mousavi S, Nouri M, Mojtahedzadeh M. The therapeutic role of vasopressin on improving lactate clearance during and after vasogenic shock: microcirculation, is it the black box?. Acta Med Iran. 2016, 54:15-23.","journal-title":"Acta Med Iran"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s40560-021-00589-x","article-title":"Hydrocortisone, ascorbic acid, and thiamine (HAT) for sepsis and septic shock: a meta-analysis with sequential trial analysis","volume":"9","author":"Na W","year":"2021","unstructured":"Na W, Shen H, Li Y, Qu D. Hydrocortisone, ascorbic acid, and thiamine (HAT) for sepsis and septic shock: a meta-analysis with sequential trial analysis. J Intensive Care. 2021, 9:75. 10.1186\/s40560-021-00589-x","journal-title":"J Intensive Care"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/0261-5614(93)90060-h","article-title":"Lactic acidosis in thiamine deficiency","volume":"12","author":"Madl C","year":"1993","unstructured":"Madl C, Kranz A, Liebisch B, Traindl O, Lenz K, Druml W. Lactic acidosis in thiamine deficiency. Clin Nutr. 1993, 12:108-111. 10.1016\/0261-5614(93)90060-h","journal-title":"Clin Nutr"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/396997-severe-metformin-associated-lactic-acidosis-managed-without-dialysis-in-an-elderly-patient-with-multiple-comorbidities-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T13:55:47Z","timestamp":1754747747000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/396997-severe-metformin-associated-lactic-acidosis-managed-without-dialysis-in-an-elderly-patient-with-multiple-comorbidities-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,9]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.89686","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,9]]}}}